Vaccination of Newborns against Hepatitis A in the Presence of Maternally Derived Antibodies

Journal of Comparative Pathology

Volumn 137, Issue SUPPL. 1, 2007, Pages

  Vidor, E ^a  

^a SANOFI PASTEUR   (France)

Author keywords

hepatitis A virus; maternally derived antibody; newborn; vaccination

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS A VACCINE; INACTIVATED VACCINE; MATERNAL ANTIBODY;

ANTIBODY RESPONSE; ARTICLE; DRUG DOSE INCREASE; DRUG DOSE REGIMEN; DRUG EFFICACY; HEPATITIS A; HEPATITIS A VIRUS; HUMAN; IMMUNOGENICITY; NEWBORN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; TREATMENT OUTCOME; VACCINATION;

ANTIBODIES, VIRAL; ANTIBODY FORMATION; HEPATITIS A; HEPATITIS A VACCINES; HEPATITIS A VIRUS; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNIZATION SCHEDULE; INFANT; INFANT, NEWBORN; VACCINATION;

HEPATITIS A VIRUS;

EID: 34250822954     PISSN: 00219975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcpa.2007.04.011     Document Type: Article

References (24)

1. Ambrosh F., Wiedermann G., Jonas S., Althaus B., Finkel B., Gluck R., and Herzog C. Immunogenicity and protectivity of a new liposomal hepatitis A vaccine. Vaccine 15 (1997) 1209-1213
2. Andre F.E., d'Hondt E., Delem A.D., and Safary A. Clinical assessment of the safety and efficacy of an inactivated hepatitis A vaccine-rationale and summary of findings. Vaccine 10 (1992) 160-168
3. Bell, B.P. and Feinstone, S.M. (2004). Hepatitis A vaccine. In: Vaccines, 4th Edit, S.A. Plotkin and W. Orenstein, Eds, W.B. Saunders, Philadelphia pp. 269-297.
4. Bell B.P., Kruszon-Moran D., Shapiro C.N., Lambert S.B., McQuillan G.M., and Margolis H.S. Hepatitis A infection in the United States: serologic results from the third national health and nutrition examination survey. Vaccine 23 (2005) 5798-5806
5. Dagan R., Amir J., Mijalovsky A., Kalmanovitch I., Bar-Yochai A., Thoelen S., Safary A., and Ashkenazi S. Immunization against hepatitis A in the first year of life: priming despite the presence of maternal antibodies. Pediatric Infectious Disease Journal 19 (2000) 1045-1052
6. Derya A., Necmi A., Emre A., and Akgun Y. Decline of maternal hepatitis A antibodies during the first 2 years of life in infants born in Turkey. American Journal of Tropical Medicine and Hygiene 73 (2005) 457-459
7. De Silvestri A., Avanzini M.A., Terulla V., Zucca S., Polatti F., and Belloni C. Decline of maternal hepatitis A virus antibody levels in infants. Acta Paediatrica 91 (2002) 882-884
8. Fiore A., Shapiro C.N., Sabin K., Labonte K., Darling K., Culver D., Bell B.P., and Margolis H.S. Hepatitis A vaccination in infants: effect of maternal antibody status on antibody persistence and response to a booster dose. Pediatric Infectious Disease Journal 22 (2003) 354-359
9. Kanra G., Yalcin S., Ceylan M., and Yurdakok K. Clinical trial to evaluate immunogenicity and safety of inactivated hepatitis A vaccination starting in 2-month-old children. Turkish Journal of Pediatrics 42 (2000) 105-108
10. Kanra G., Yalcin S.S., Kara A., Ozmert E., and Yurdakok K. Hepatitis A booster vaccine in children after infant immunization. Pediatric Infectious Disease Journal 21 (2002) 727-730
11. Lagos R., Munoz A., Dumas R., Pichon S., Zambrano B., Levine M., and Vidor E. Immunological priming of one dose of inactivated hepatitis A vaccine given during the first year of life in presence of maternal antibodies. Vaccine 21 (2003) 3730-3733
12. Letson G.W., Shapiro C.N., Kuehn D., Gardea C., Welty T.K., Krause D.S., Lambert S.B., and Margolis H.S. Effect of maternal antibody on immunogenicity of hepatitis A vaccine in infants. Journal of Pediatrics 144 (2004) 327-332
13. Lieberman J.M., Chang S., Partridge S., Hollister J.C., Kaplan K.M., Jensen E.H., Kuter B., and Ward J.I. Kinetics of maternal hepatitis A antibody decay in infants: implications for vaccine use. Pediatric Infectious Disease Journal 21 (2002) 347-348
14. Lieberman, J.M., Marcy, M., Partridge, S. and Ward, J.I. (1998). Evaluation of a HA vaccine in infants: effects of maternal antibodies on antibody response. In: Proceedings of the 36th Annual Meeting of the Infectious Diseases Society of America, Denver, CO.
15. Linder N., Karetnyi Y., Gidony Y., Dagan R., Ohel G., Levin E., Mendelson E., and Barzilai A. Decline of hepatitis A antibodies during the first 7 months of life in full-term and preterm infants. Infection 27 (1999) 128-131
16. Linder N., Karetnyi Y., Gidony Y., Ohel G., Levin E., Kuint J., Davidovich N., Gidony I., Mendelson E., and Barzilai A. Placental transfer of hepatitis A antibodies in full term and pre-term infants. Pediatric Infectious Disease Journal 16 (1997) 245-247
17. Lopez E.L., Contrini M.M., Xifro M.C., Cattaneo M.A., Zambrano B., Dumas R., Rouyre N., and Weber F. Hepatitis A vaccination in Argentinean infants: comparison of two vaccination schedules. Vaccine 25 (2007) 102-108
18. Nalin D.R. Vaqta. Future Drugs 20 (1995) 24-29
19. Piazza M., Safary A., Vegnente A., Soncini R., Pensati P., Sardo M., Orlando R., Tosone G., and Picciotto L. Safety and immunogenicity of hepatitis A vaccine in infants: a candidate for inclusion in the childhood vaccination programme. Vaccine 17 (1999) 585-588
20. Siegrist C.-A., Cordova M., Brandt C., Barrios C., Berney M., Tougne C., Kovarik J., and Lambert P.-H. Determinants of infant responses to vaccines in the presence of maternal antibodies. Vaccine 16 (1998) 1409-1414
21. Usonis V., Bakasenas V., Valentelis R., Katiliene G., Vidzeniene D., and Herzog C. Antibody titers after primary and booster vaccination of infants and young children with a virosomal hepatitis A vaccine (Epaxal). Vaccine 21 (2003) 4588-4592
22. Van Hattum J., and Chen X.Q. Hepatitis A: infection, detection, vaccination and immunity. The Netherlands Journal of Medicine 55 (1999) 142-150
23. Vidor E., Dumas R., Porteret V., Bailleux F., and Veitch K. Aventis Pasteur vaccines containing inactivated hepatitis A virus: a compilation of immunogenicity results. European Journal of Clinical Microbiology and Infectious Disease 23 (2004) 300-309
24. Zanetti A., Pregliasco F., Andreassi A., Pozzi A., Vigano P., Cargnel A., Briantais P., and Vidor E. Does immunoglobulin interfere with the immunogenicity to Pasteur Mérieux inactivated hepatitis A vaccine?. Journal of Hepatology 26 (1997) 25-30